Results of an abbreviated phase II study of AKT inhibitor...

Gynecologic Oncology Reports 2020 / 05 Vol. 32

Results of an abbreviated phase II study of AKT inhibitor MK-2206 in the treatment of recurrent platinum-resistant high grade serous ovarian, fallopian tube, or primary peritoneal carcinoma (NCT 01283035)

Lee, Elizabeth K., Tan-Wasielewski, Zhenying, Aghajanian, Carol, Coleman, Robert L., Curtis, Jennifer, Hirsch, Michelle S., Matulonis, Ursula A., Cantley, Lewis C., Mills, Gordon B., Doyle, L. Austin,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
32
Language:
english
Journal:
Gynecologic Oncology Reports
DOI:
10.1016/j.gore.2020.100546
Date:
May, 2020
File:
PDF, 202 KB
english, 2020
Conversion to is in progress
Conversion to is failed